John Johnson, Director at Xeris Biopharma Holdings, Inc. (XERS), sold 107,500 shares at $7.32 ($787K) on 2025-08-13, disclosed to the SEC on 2025-08-15.
Open-market sale of $787k XERS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |